Learn recommended dosages, when higher doses are needed, and why testing matters before supplementing. Compare minoxidil vs finasteride, including how each works, differences in treatment approach, potential side effects, and what men should know about hair loss options. Learn about common and potential minoxidil side effects, why they occur, and what men should know before starting this popular hair loss treatment. Some clinics offer virtual follow-ups or consultations when appropriate, but most initial visits and labs must be completed in person. Our team focuses on optimizing male hormones, energy, mood, and metabolism to support your overall health. Most men experiencing low energy, reduced performance, low libido, weight challenges, or hormone imbalance symptoms qualify for customized treatment.
In most cases, men need to have both low levels of testosterone in their blood and several symptoms of low testosterone to go on therapy. If your doctor diagnoses low testosterone, other tests may be considered before therapy. For instance, being overweight, having diabetes or thyroid problems, and taking certain medications, such as glucocorticoids and other steroids, can affect levels.
This means that they aren’t tested or evaluated for their effectiveness and could contain undisclosed ingredients or have unexpected side effects. Moreover, 10 percent of the supplements tested contained ingredients that have a negative effect on testosterone, according to the study. However, there isn’t enough research to support their effectiveness, and these products may not actually have ingredients that support their claims.
The most common chromosomal abnormality identified is 47,XXY, also known as KS, although other chromosomal abnormalities can also be found. KaryotypeA karyotype should be considered in men with unexplained hypergonadotropic hypogonadism. Bone DensitometryMen with testosterone deficiency are at increased risk of bone density loss. For clinicians experienced in managing prolactinomas, bromocriptine or cabergoline may be prescribed without endocrinology input.
Although study exclusion criteria included uncontrolled hypertension, unstable angina, myocardial infarction within the past three months, and congestive heart failure, there was a higher rate of hyperlipidemia and statin use at baseline in the testosterone therapy group as compared to the placebo group. While seven of the trials in the above analysis showed decreased, but statistically insignificant, odds of having a cardiac event while on testosterone therapy, one trial did show an increased risk. Men who are on testosterone therapy should be advised to report the occurrence of any possible cardiovascular symptoms, such as chest pain, shortness of breath, dizziness, or transient loss of consciousness, during routine follow-up visits. The risk corresponded to an additional 10 cases per 10,000 person-years, which, while low in absolute terms, raised concern about using testosterone therapy in men who may be at increased risk for VTE prior to commencement of therapy.362 Conversely, a population-based retrospective case-control study utilizing a UK clinical database of 19,215 patients with confirmed VTE showed that there was increased risk of VTE in the first 6 months of testosterone therapy. An increase in serum PSA of 0.5 ng/mL or greater was found in 3 men while on testosterone therapy, and 4 experienced a decrease of the same magnitude on treatment. The authors of the paper could not attribute the cancer diagnosis to testosterone treatment alone considering prostate cancer develops in as many as one quarter of PIN+ patients within three years.
"I had an amazing experience at Gameday Men’s Health Aventura! "I had a fantastic experience at Gameday Men’s Health. Highly recommend for those men needing a little extra energy." More than 400 clinics nationwide designed specifically for men — comfortable, discreet, and purpose-built for results.
The first testosterone measurement should be obtained two to four weeks after initial implant to determine if the number of inserted pellets needs to be increased or decreased to achieve the appropriate therapeutic level. While no data exist on the optimal timing of the blood draw within a cycle, it has historically been recommended that blood draws be conducted mid-cycle. Although steady-state levels are generally reached within days following commencement, a longer interval takes into account the potential decreases in endogenous testosterone production when on exogenous testosterone. For patients on daily medication, the Panel recommends that patients use medication the day of follow-up blood work. Patients who have been prescribed testosterone should have regular laboratory testing conducted to confirm that therapeutic levels of testosterone are maintained, especially given the suppression of LH by exogenous testosterone and the subsequent decrease in endogenous testosterone production by the testes. With respect to testosterone specifically, Grober et al. conducted an analysis of compounded testosterone creams/gels from 10 pharmacies in Toronto, Canada.410 Each pharmacy was given two prescriptions for 50 mg of testosterone, separated by 1 month to assess both intra-pharmacy and inter-pharmacy consistency. Considerable variation in dosages and in ingredients results.
Although the absolute risks of POME and anaphylaxis require ongoing study, data from 342 patients undergoing 3,022 injections (1,000 mg in 4 mL) over a period of 3.5 years demonstrated that POME occurred after 1.9% of injections (12% of patients experienced at least one POME), with coughing episodes lasting 1-10 minutes in duration.443 All episodes were managed conservatively in the clinic, with no supplemental oxygen required. In a 12-week study in 82 men, 72.6% of patients achieved a total testosterone concentration within the physiological range at steady state.434 Men treated with the agent were compared to a group of patients given 5 mg of a testosterone gel formulation, and no differences in mean testosterone serum levels were observed between the two groups.435 The study showed 92% of buccal versus 83% of gel patients achieved testosterone levels in the physiologic range. In the case of topical patches, the testosterone levels achieved directly relate to the amount of surface area exposed to drug.430 Topical gels and liquids generally demonstrate less variability in absorption uptake when compared to other therapies.417 After application, steady state levels are achieved within hours, with testosterone levels returning to baseline within 4 days of discontinuation.418, 419